Real Brands Inc (RLBD)
0.0021
0.00 (0.00%)
USD |
OTCM |
Apr 26, 13:21
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 5.650M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -70.59% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -0.8103 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 98.88% |
Profile
Real Brands Inc is a publicly traded, vertically integrated, early entrant in the hemp-derived cannabinol (CBD) market that specializes in hemp CBD oil/isolate extraction, wholesaling of CBD oils and isolate, manufacturing, production, and sales of hemp-derived CBD consumer, celebrity brands, and white label products. |
URL | https://www.realbrandsusa.com |
Investor Relations URL | N/A |
HQ State/Province | Rhode Island |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Value |
Next Earnings Release | May. 15, 2024 (est.) |
Last Earnings Release | Nov. 17, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Real Brands Inc is a publicly traded, vertically integrated, early entrant in the hemp-derived cannabinol (CBD) market that specializes in hemp CBD oil/isolate extraction, wholesaling of CBD oils and isolate, manufacturing, production, and sales of hemp-derived CBD consumer, celebrity brands, and white label products. |
URL | https://www.realbrandsusa.com |
Investor Relations URL | N/A |
HQ State/Province | Rhode Island |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Value |
Next Earnings Release | May. 15, 2024 (est.) |
Last Earnings Release | Nov. 17, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |